# Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial

> **NCT03342495** · NA · COMPLETED · sponsor: **University of Calgary** · enrollment: 337 (actual)

## Conditions studied

- Diabetes
- Endocrine System Diseases
- Gastro-Intestinal Disorder
- Neuro-Degenerative Disease
- Epilepsy
- Autoimmune Diseases
- Renal Disease
- Cardiac Disease
- Metabolic Disease
- Genetic Diseases, Inborn
- Respiratory Disease
- Hematologic Diseases
- Autism Spectrum Disorder
- Fetal Alcohol Spectrum Disorders
- Traumatic Brain Injury
- Stroke

## Interventions

- **OTHER:** Patient Navigator
- **OTHER:** Usual Care

## Key facts

- **NCT ID:** NCT03342495
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-06
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-07
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2023-06-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03342495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03342495, "Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03342495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*